drugset / Trial / NCT00231517

Randomised Double Blind Placebo Controlled Cross Over Design of the Efficacy of Topical Morphine for Inflammatory Pain in Children With Epidermolysis Bullosa

NCT00231517 ↗

Phase 4 Completed Institute of Child Health
RandomizedCrossoverDouble-blindTreatment

Summary

Randomised Double blind placebo controlled cross over design study of the efficacy of morphine for inflammatory pain in children with Epidermolysis Bullosa

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified — Topical

Indications